Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells.

[1]  J. Kos,et al.  Internalization of Exogenous Cystatin F Supresses Cysteine Proteases and Induces the Accumulation of Single-chain Cathepsin L by Multiple Mechanisms* , 2011, The Journal of Biological Chemistry.

[2]  C. Watts,et al.  Glycosylation Directs Targeting and Activation of Cystatin F from Intracellular and Extracellular Sources , 2009, Traffic.

[3]  J. Kos,et al.  Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X , 2008, Journal of leukocyte biology.

[4]  Hidde L. Ploegh,et al.  The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.

[5]  C. Watts,et al.  Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis , 2008, The EMBO journal.

[6]  A. W. Schüttelkopf,et al.  Structural Basis of Reduction-dependent Activation of Human Cystatin F* , 2006, Journal of Biological Chemistry.

[7]  J. Kos,et al.  Differentiation‐ and maturation‐dependent content, localization, and secretion of cystatin C in human dendritic cells , 2005, Journal of leukocyte biology.

[8]  J. Kos,et al.  Inhibitory properties of cystatin F and its localization in U937 promonocyte cells , 2005, The FEBS journal.

[9]  P. Pierre,et al.  Cystatin F is secreted, but artificial modification of its C-terminus can induce its endocytic targeting. , 2004, Experimental cell research.

[10]  Samantha J. Hardy,et al.  Maturation of DC is associated with changes in motile characteristics and adherence. , 2004, Cell motility and the cytoskeleton.

[11]  J. Villadangos,et al.  The Protease Inhibitor Cystatin C Is Differentially Expressed among Dendritic Cell Populations, but Does Not Control Antigen Presentation 1 , 2003, The Journal of Immunology.

[12]  A. Rudensky,et al.  Lysosomal cysteine proteases regulate antigen presentation , 2003, Nature Reviews Immunology.

[13]  H. Kalbacher,et al.  Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells , 2002, European journal of immunology.

[14]  J. Wassélius,et al.  Regulated expression and intracellular localization of cystatin F in human U937 cells. , 2002, European journal of biochemistry.

[15]  K. Matsushima,et al.  Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. , 2002, International immunology.

[16]  G. Salvesen,et al.  Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. , 2002, Current pharmaceutical design.

[17]  M. Lamers,et al.  Structure of a Cys25-->Ser mutant of human cathepsin S. , 2002, Acta crystallographica. Section D, Biological crystallography.

[18]  C. Pham,et al.  Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. , 2002, The Journal of clinical investigation.

[19]  J. Kos,et al.  Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis , 2001, British Journal of Cancer.

[20]  David E. Misek,et al.  Profiling Changes in Gene Expression during Differentiation and Maturation of Monocyte-derived Dendritic Cells Using Both Oligonucleotide Microarrays and Proteomics* , 2001, The Journal of Biological Chemistry.

[21]  K. Matsushima,et al.  Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. , 2000, Blood.

[22]  S. Nishimura,et al.  Genomic construct and mapping of the gene for CMAP (leukocystatin/cystatin F, CST7) and identification of a proximal novel gene, BSCv (C20orf3). , 2000, Genomics.

[23]  I J Christensen,et al.  Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  R. Ménard,et al.  Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine. , 2000, Journal of molecular biology.

[25]  S. Hashimoto,et al.  Serial analysis of gene expression in human monocyte-derived dendritic cells. , 1999, Blood.

[26]  T. Ley,et al.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Barrett,et al.  Inhibition of Mammalian Legumain by Some Cystatins Is Due to a Novel Second Reactive Site* , 1999, The Journal of Biological Chemistry.

[28]  D. Turk,et al.  Crystal structure of MHC class II‐associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S , 1999, The EMBO journal.

[29]  G. Dranoff,et al.  Cathepsin S required for normal MHC class II peptide loading and germinal center development. , 1999, Immunity.

[30]  A. Rudensky,et al.  Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. , 1999, Immunity.

[31]  R. Gentz,et al.  Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor* , 1998, The Journal of Biological Chemistry.

[32]  S. Menon,et al.  Leukocystatin, A New Class II Cystatin Expressed Selectively by Hematopoietic Cells* , 1998, The Journal of Biological Chemistry.

[33]  I. Mellman,et al.  Developmental Regulation of Invariant Chain Proteolysis Controls MHC Class II Trafficking in Mouse Dendritic Cells , 1998, Cell.

[34]  A. Rudensky,et al.  Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.

[35]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[36]  H. Chapman,et al.  Endosomal proteolysis and MHC class II function. , 1998, Current opinion in immunology.

[37]  J. Kos,et al.  Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  J. Kos,et al.  Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. , 1997, Journal of immunological methods.

[39]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.

[40]  V. Turk,et al.  Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L , 1996, The Journal of experimental medicine.

[41]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[42]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[43]  M. Smyth,et al.  Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. , 1995, Journal of immunology.

[44]  V. Turk,et al.  Expression of full-length human procathepsin L cDNA in Escherichia coli and refolding of the expression product. , 1995, Biological chemistry Hoppe-Seyler.

[45]  C. Davis,et al.  Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment , 1994, The Journal of cell biology.

[46]  Bernhard Dobberstein,et al.  The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. , 1993, Journal of cell science.

[47]  W. Bode,et al.  cystatins: protein inhibitors of cysteine proteinases , 2001 .

[48]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[49]  G. Gaidano,et al.  Integrin distribution and cytoskeleton organization in normal and malignant monocytes. , 1990, Leukemia.

[50]  R. Huber,et al.  The refined 2.4 A X‐ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. , 1990, The EMBO journal.

[51]  J. Kos,et al.  Efficient removal of cathepsin L from active cathepsin X using immunoprecipitation technique , 2009 .

[52]  D. Turk,et al.  Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L , 2005, Biological chemistry.

[53]  N. Rawlings,et al.  Evolution of proteins of the cystatin superfamily , 2005, Journal of Molecular Evolution.

[54]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.